Mats Walder

2.6k total citations
83 papers, 2.0k citations indexed

About

Mats Walder is a scholar working on Molecular Medicine, Infectious Diseases and Pharmacology. According to data from OpenAlex, Mats Walder has authored 83 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Medicine, 23 papers in Infectious Diseases and 22 papers in Pharmacology. Recurrent topics in Mats Walder's work include Antibiotic Resistance in Bacteria (24 papers), Antibiotics Pharmacokinetics and Efficacy (22 papers) and Bacterial Identification and Susceptibility Testing (11 papers). Mats Walder is often cited by papers focused on Antibiotic Resistance in Bacteria (24 papers), Antibiotics Pharmacokinetics and Efficacy (22 papers) and Bacterial Identification and Susceptibility Testing (11 papers). Mats Walder collaborates with scholars based in Sweden, Switzerland and Finland. Mats Walder's co-authors include Arne Forsgren, Inga Odenholt, Jan Ursing, Eva Melander, Marlene Wullt, Karin Sandstedt, Johan Tham, S Cronberg, Lennart Sanzén and J. Renneberg and has published in prestigious journals such as Journal of Clinical Microbiology, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Mats Walder

83 papers receiving 1.8k citations

Peers

Countries citing papers authored by Mats Walder

Since Specialization

Citations

This map shows the geographic impact of Mats Walder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mats Walder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mats Walder more than expected).

Fields of papers citing papers by Mats Walder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mats Walder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mats Walder. The network helps show where Mats Walder may publish in the future.

Co-authorship network of co-authors of Mats Walder

This figure shows the co-authorship network connecting the top 25 collaborators of Mats Walder. A scholar is included among the top collaborators of Mats Walder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mats Walder. Mats Walder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hydrogen Peroxide Vapor Decontamination in a Patient Room Using Feline Calicivirus and Murine Norovirus as Surrogate Markers for Human Norovirus 2016 ·Infection Control and Hospital Epidemiology ·(unknown), Mats Walder, Nathalie Y. Uzcátegui, Inga Odenholt, Peter Lanbeck, Patrik Medstrand, Anders Widell	15
2	Prevalence of extended-spectrum beta-lactamase-producing bacteria in food 2012 ·Infection and Drug Resistance ·Johan Tham, Inga Odenholt, Mats Walder, (unknown)	15
3	Duration of colonization with extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers’ diarrhoea 2012 ·Scandinavian Journal of Infectious Diseases ·Johan Tham, Mats Walder, Eva Melander, Inga Odenholt	39
4	Development of a real-time SYBRGreen PCR assay for rapid detection of acquired AmpC in Enterobacteriaceae 2010 ·Journal of Microbiological Methods ·Alma Brolund, Karin Tegmark Wisell, Petra Edquist, (unknown), Mats Walder, Christian G. Giske	27
5	Pharmacodynamic Studies of Vancomycin, Metronidazole and Fusidic Acid against <i>Clostridium difficile</i> 2007 ·Chemotherapy ·Inga Odenholt, Mats Walder, Marlene Wullt	27
6	Activity of Three Disinfectants and Acidified Nitrite AgainstClostridium difficileSpores 2003 ·Infection Control and Hospital Epidemiology ·Marlene Wullt, Inga Odenholt, Mats Walder	65
7	Antimicrobial Susceptibilities and Biotypes of Arcanobacterium haemolyticum Blood Isolates 1999 ·European Journal of Clinical Microbiology & Infectious Diseases ·Petteri Carlson, Jussi Korpela, Mats Walder, (unknown)	23
8	Bacteriologic evidence of infection caused by coagulase-negative staphylococci in total hip replacement 1998 ·The Journal of Arthroplasty ·Håkan Ringberg, Lennart Sanzén, Anders Thorén, Mats Walder	5
9	A Hospital Outbreak of High-level β-Lactam-Resistant Enterobacter spp.: Association more with Ampicillin and Cephalosporin Therapy than with Nosocomial Transmission 1996 ·Scandinavian Journal of Infectious Diseases ·Mats Walder, Sara Hæggman, Kjell Tullus, Lars Burman	10
10	Ampicillin plus Mecillinam vs. Cefotaxime/Cefadroxil Treatment of Patients with Severe Pneumonia or Pyelonephritis: a Double-Blind Multicentre Study Evaluated by Intention-to-Treat Analysis 1995 ·Scandinavian Journal of Infectious Diseases ·S Cronberg, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Anders Thorén, Mats Walder, (unknown)	11
11	Penetration of penicillin V to tonsillar surface fluid in healthy individuals and in patients with acute tonsillitis 1993 ·The Journal of Laryngology & Otology ·Anna Stjernquist‐Desatnik, (unknown), Mats Walder	28
12	Interactions of drugs acting against Staphylococcus aureus in vitro and in a mouse model 1993 ·Journal of Infection ·J. Renneberg, Eva Nordberg Karlsson, Berit Nilsson, Mats Walder	10
13	Pharmacokinetics of ceftazidime in acutely Ill hospitalised elderly patients 1992 ·European Journal of Clinical Microbiology & Infectious Diseases ·Malin Jonsson Fagerlund, Mats Walder	8
14	Air contamination during total hip arthroplasty in an ultraclean air enclosure using different types of staff clothing 1990 ·The Journal of Arthroplasty ·Lennart Sanzén, (unknown), Mats Walder	26
15	A method to evaluate the cleaning and disinfectant action of surface disinfectants 1989 ·Journal of Hospital Infection ·Mats Walder, (unknown), Bengt‐Olof Nilsson	3
16	A mouse model for simultaneous pharmacokinetic and efficacy studies of antibiotics at sites of infection 1988 ·Journal of Antimicrobial Chemotherapy ·J. Renneberg, Mats Walder	7
17	Antibiotic resistance of coagulase-negative staphylococci in an orthopaedic department 1988 ·Journal of Hospital Infection ·Lennart Sanzén, Mats Walder	38
18	Failure of a Single Dose of 100 mg Ofloxacin in Lower Urinary Tract Infections in Females 1987 ·Scandinavian Journal of Infectious Diseases ·(unknown), Mats Walder, Arne Forsgren	26
19	Penetration of ampicillin, doxycycline and gentamicin into interstitial fluid in rabbits and of penicillin V and pivampicillin in humans measured with subcutaneously implanted cotton threads 1981 ·Infection ·(unknown), Mats Walder	6
20	Failure of Excessive Doses of Ampieillin to Prevent Bacterial Relapse in the Treatment of Acute. Pyelonephritis 1980 ·Acta Medica Scandinavica ·(unknown), (unknown), Mats Walder, S Cronberg	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact